Patent · US Active

Methods and compositions for treating Siglec-8 associated diseases

US10183996B2 · kind B2 · utility

3Cited by
55References
58Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 27, 2015
Grant dateJan 22, 2019
Priority date
Expiry dateFeb 27, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/732
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides methods and compositions for the prevention and treatment of Siglec-8 associated diseases such as chronic rhino sinusitis with concomitant asthma and aspirin-exacerbated respiratory disease. In particular, the invention provides methods for the prevention and treatment of Siglec-8 associated diseases through administration of antibodies or agonists that bind to human Siglec-8 or compositions comprising said antibodies or agonists. The invention also provides articles of manufacture or kits comprising antibodies or agonists that bind to human Siglec-8 for the prevention and treatment of Siglec-8 associated diseases such as chronic rhinosinusitis with concomitant asthma and aspirin-exacerbated respiratory disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.